From protein-protein interactions to rational drug design: are computational methods up to the challenge?
Identifieur interne : 000248 ( PubMed/Corpus ); précédent : 000247; suivant : 000249From protein-protein interactions to rational drug design: are computational methods up to the challenge?
Auteurs : Edgar D. Coelho ; Joel P. Arrais ; José Luís OliveiraSource :
- Current topics in medicinal chemistry [ 1873-4294 ] ; 2013.
English descriptors
- KwdEn :
- MESH :
- chemical , antagonists & inhibitors : Proteins.
- chemical , chemistry : Proteins.
- chemical , metabolism : Proteins.
- methods : Protein Interaction Mapping.
- Computational Biology, Drug Design, Humans, Protein Binding.
Abstract
The study of protein-protein interactions (PPIs) has been growing for some years now, mainly as a result of easy access to high-throughput experimental data. Several computational approaches have been presented throughout the years as means to infer PPIs not only within the same species, but also between different species (e.g., host-pathogen interactions). The importance of unveiling the human protein interaction network is undeniable, particularly in the biological, biomedical and pharmacological research areas. Even though protein interaction networks evolve over time and can suffer spontaneous alterations, occasional shifts are often associated with disease conditions. These disorders may be caused by external pathogens, such as bacteria and viruses, or by intrinsic factors, such as auto-immune disorders and neurological impairment. Therefore, having the knowledge of how proteins interact with each other will provide a great opportunity to understand pathogenesis mechanisms, and subsequently support the development of drugs focused on very specific disease pathways and re-targeting already commercialized drugs to new gene products. Computational methods for PPI prediction have been highlighted as an interesting option for interactome mapping. In this paper we review the techniques and strategies used for both experimental identification and computational inference of PPIs. We will then discuss how this knowledge can be used to create protein interaction networks (PINs) and the various methodologies applied to characterize and predict the so-called "disease genes" and "disease networks". This will be followed by an overview of the strategies employed to predict drug targets.
PubMed: 23548023
Links to Exploration step
pubmed:23548023Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">From protein-protein interactions to rational drug design: are computational methods up to the challenge?</title>
<author><name sortKey="Coelho, Edgar D" sort="Coelho, Edgar D" uniqKey="Coelho E" first="Edgar D" last="Coelho">Edgar D. Coelho</name>
<affiliation><nlm:affiliation>Department of Electronics, Telecommunications and Informatics (DETI), Institute of Electronics and Telematics Engineering of Aveiro (IEETA), University of Aveiro, Portugal.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Arrais, Joel P" sort="Arrais, Joel P" uniqKey="Arrais J" first="Joel P" last="Arrais">Joel P. Arrais</name>
</author>
<author><name sortKey="Oliveira, Jose Luis" sort="Oliveira, Jose Luis" uniqKey="Oliveira J" first="José Luís" last="Oliveira">José Luís Oliveira</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23548023</idno>
<idno type="pmid">23548023</idno>
<idno type="wicri:Area/PubMed/Corpus">000248</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000248</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">From protein-protein interactions to rational drug design: are computational methods up to the challenge?</title>
<author><name sortKey="Coelho, Edgar D" sort="Coelho, Edgar D" uniqKey="Coelho E" first="Edgar D" last="Coelho">Edgar D. Coelho</name>
<affiliation><nlm:affiliation>Department of Electronics, Telecommunications and Informatics (DETI), Institute of Electronics and Telematics Engineering of Aveiro (IEETA), University of Aveiro, Portugal.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Arrais, Joel P" sort="Arrais, Joel P" uniqKey="Arrais J" first="Joel P" last="Arrais">Joel P. Arrais</name>
</author>
<author><name sortKey="Oliveira, Jose Luis" sort="Oliveira, Jose Luis" uniqKey="Oliveira J" first="José Luís" last="Oliveira">José Luís Oliveira</name>
</author>
</analytic>
<series><title level="j">Current topics in medicinal chemistry</title>
<idno type="eISSN">1873-4294</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Computational Biology</term>
<term>Drug Design</term>
<term>Humans</term>
<term>Protein Binding</term>
<term>Protein Interaction Mapping (methods)</term>
<term>Proteins (antagonists & inhibitors)</term>
<term>Proteins (chemistry)</term>
<term>Proteins (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Protein Interaction Mapping</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Computational Biology</term>
<term>Drug Design</term>
<term>Humans</term>
<term>Protein Binding</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The study of protein-protein interactions (PPIs) has been growing for some years now, mainly as a result of easy access to high-throughput experimental data. Several computational approaches have been presented throughout the years as means to infer PPIs not only within the same species, but also between different species (e.g., host-pathogen interactions). The importance of unveiling the human protein interaction network is undeniable, particularly in the biological, biomedical and pharmacological research areas. Even though protein interaction networks evolve over time and can suffer spontaneous alterations, occasional shifts are often associated with disease conditions. These disorders may be caused by external pathogens, such as bacteria and viruses, or by intrinsic factors, such as auto-immune disorders and neurological impairment. Therefore, having the knowledge of how proteins interact with each other will provide a great opportunity to understand pathogenesis mechanisms, and subsequently support the development of drugs focused on very specific disease pathways and re-targeting already commercialized drugs to new gene products. Computational methods for PPI prediction have been highlighted as an interesting option for interactome mapping. In this paper we review the techniques and strategies used for both experimental identification and computational inference of PPIs. We will then discuss how this knowledge can be used to create protein interaction networks (PINs) and the various methodologies applied to characterize and predict the so-called "disease genes" and "disease networks". This will be followed by an overview of the strategies employed to predict drug targets.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23548023</PMID>
<DateCreated><Year>2013</Year>
<Month>04</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>02</Month>
<Day>07</Day>
</DateCompleted>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4294</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>13</Volume>
<Issue>5</Issue>
<PubDate><Year>2013</Year>
</PubDate>
</JournalIssue>
<Title>Current topics in medicinal chemistry</Title>
<ISOAbbreviation>Curr Top Med Chem</ISOAbbreviation>
</Journal>
<ArticleTitle>From protein-protein interactions to rational drug design: are computational methods up to the challenge?</ArticleTitle>
<Pagination><MedlinePgn>602-18</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The study of protein-protein interactions (PPIs) has been growing for some years now, mainly as a result of easy access to high-throughput experimental data. Several computational approaches have been presented throughout the years as means to infer PPIs not only within the same species, but also between different species (e.g., host-pathogen interactions). The importance of unveiling the human protein interaction network is undeniable, particularly in the biological, biomedical and pharmacological research areas. Even though protein interaction networks evolve over time and can suffer spontaneous alterations, occasional shifts are often associated with disease conditions. These disorders may be caused by external pathogens, such as bacteria and viruses, or by intrinsic factors, such as auto-immune disorders and neurological impairment. Therefore, having the knowledge of how proteins interact with each other will provide a great opportunity to understand pathogenesis mechanisms, and subsequently support the development of drugs focused on very specific disease pathways and re-targeting already commercialized drugs to new gene products. Computational methods for PPI prediction have been highlighted as an interesting option for interactome mapping. In this paper we review the techniques and strategies used for both experimental identification and computational inference of PPIs. We will then discuss how this knowledge can be used to create protein interaction networks (PINs) and the various methodologies applied to characterize and predict the so-called "disease genes" and "disease networks". This will be followed by an overview of the strategies employed to predict drug targets.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coelho</LastName>
<ForeName>Edgar D</ForeName>
<Initials>ED</Initials>
<AffiliationInfo><Affiliation>Department of Electronics, Telecommunications and Informatics (DETI), Institute of Electronics and Telematics Engineering of Aveiro (IEETA), University of Aveiro, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Arrais</LastName>
<ForeName>Joel P</ForeName>
<Initials>JP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Oliveira</LastName>
<ForeName>José Luís</ForeName>
<Initials>JL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Curr Top Med Chem</MedlineTA>
<NlmUniqueID>101119673</NlmUniqueID>
<ISSNLinking>1568-0266</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D019295">Computational Biology</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D015195">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011485">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D025941">Protein Interaction Mapping</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011506">Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000037">antagonists & inhibitors</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>1</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>2</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>3</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>4</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>4</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>2</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pii">CTMC-EPUB-20130329-5</ArticleId>
<ArticleId IdType="pubmed">23548023</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/TelematiV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000248 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000248 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Ticri/CIDE |area= TelematiV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:23548023 |texte= From protein-protein interactions to rational drug design: are computational methods up to the challenge? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23548023" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a TelematiV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |